ClinConnect ClinConnect Logo
Search / Trial NCT06677346

Parity and Respiratory Muscle Strength in Women

Launched by MEDIPOL UNIVERSITY · Nov 5, 2024

Trial Information

Current as of July 09, 2025

Recruiting

Keywords

ClinConnect Summary

This clinical trial, titled "Parity and Respiratory Muscle Strength in Women," is exploring how having children (known as parity) affects the strength of breathing muscles in women. The researchers want to understand if there is a connection between the number of pregnancies a woman has had and how well her respiratory muscles function. This study is currently looking for women aged 20 to 45 who are interested in participating.

To be eligible for the trial, participants should not have a body mass index (BMI) of 30 or higher, and they should not have any history of serious health issues like heart problems, lung diseases, or neurological disorders. Women who smoke, have had back surgery, or are currently undergoing cancer treatment are also not eligible. If you join the study, you can expect to participate in assessments that will help researchers gather valuable information about respiratory muscle strength in relation to childbirth.

Gender

FEMALE

Eligibility criteria

  • Inclusion Criteria:
  • Being between 20-45 years old
  • Being female
  • Exclusion Criteria:
  • Having a body mass index of ≥30 kg/m2
  • History of cardiovascular, neurological, pulmonary disease
  • Being receiving active cancer treatment
  • Having a history of lumbar surgery
  • History of smoking
  • Being a licensed athlete

About Medipol University

Medipol University is a leading academic institution dedicated to advancing medical research and clinical innovation. With a strong emphasis on interdisciplinary collaboration, the university conducts rigorous clinical trials aimed at improving patient outcomes and enhancing healthcare practices. Leveraging state-of-the-art facilities and a team of experienced researchers and healthcare professionals, Medipol University is committed to contributing to the global medical community through ethical research and the development of novel therapeutic strategies. The institution fosters an environment of academic excellence and integrity, ensuring that all trials adhere to the highest standards of safety and efficacy.

Locations

Istanbul, , Turkey

Patients applied

0 patients applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported